• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Industry

  • Print
  • Share
  • E-mail

Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research

On June 14, 2013, FDA conducted a public meeting on human immunodeficiency virus (HIV) Patient-Focused Drug Development and HIV Cure Research. FDA is interested in obtaining patient input on the impact of HIV on daily life, currently available therapies to treat the condition, and patients’ views on issues related to HIV cure research.


June 14, 2013 


9:30 a.m. to 5:30 p.m 


FDA White Oak Campus 10903 New Hampshire Ave.
Building 31, Room 1503A (Great Room)                                                                                   
Silver Spring, MD 20993 

(Information about arrival to FDA's White Oak campus)  


To register for this meeting, visit http://patientfocusedhiv.eventbrite.com.
Registration closed on June 5, 2013.  

To submit comments to the docket, go to http://www.regulations.gov/#!docketDetail;D=FDA-2013-N-0473.
The comment period has re-opened. Electronic and written comments may be submitted to the docket until September 3, 2013.

Webcast Recordings (archived)

Summary Report